Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Sequencing the Strange Communities: Taking on Metagenomics

    Jun 24, 2014, 07:00 AM by Michael Croft
    Bio-IT World | In another look at the Hi-C process for sorting out disparate bits of DNA, Jonathan Eisen’s lab at UC Davis tweaks the Markov Cluster Algorithm to take on metagenomics. The results need further attention, but could be extremely useful for joining plasmids and chromosomes from the same species.
    Full story
  • PCI WELCOMES ROBBIE STEWART TO THE EUROPEAN BUSINESS DEVELOPMENT TEAM

    Jun 24, 2014, 00:00 AM by Michael Croft
    , UK - Jun 24, 2014 - Packaging Coordinators Inc. (PCI) is pleased to welcome Robbie Stewart to its European business development team
    Full story
  • Australian Research Institute IDs Novel Syndrome Variants with NextCODE Tools

    Jun 23, 2014, 13:00 PM by Michael Croft
    Bio-IT World News Brief | The ANZAC Research Institute in Sydney, Australia, has used NextCODE Health's Clinical Sequence Analyzer and Sequence Miner tools to ID novel sequence variants behind X-linked Charcot-Marie-Tooth syndrome (CMTX).
    Full story
  • 23andMe Seeks FDA Approval for Health Report on Single Condition

    Jun 20, 2014, 12:45 PM by Michael Croft
    Bio-IT World | Today, 23andMe's new chief legal and regulatory officer, Kathy Hibbs, announced that the company has submitted a 510(k) to the FDA, seeking approval to tell customers whether they carry mutations for the rare disease Bloom syndrome. The move signals a cooperative, incremental approach to restoring the 23andMe health reports that the FDA shut down last November.
    Full story
  • PacBio Users Share New Tools and Applications at Meeting in Baltimore

    Jun 19, 2014, 10:05 AM by Michael Croft
    Bio-IT World | At the annual Pacific Biosciences user group meeting in Baltimore, geneticists and bioinformaticians gathered this week to discuss how long-read sequencing is opening up previously intractable problems. Rapid de novo assembly of whole genomes was a major topic of conversation, while users unveiled new computational tools that greatly speed up long-read assemblies, and PacBio announced plans for updated chemistry and high-throughput HLA typing.
    Full story
  • rgest-ever TMF Survey Reveals Lagging Technology Adoption and Manual Processes Significantly Impacting Clinical Trial Operations

    Jun 19, 2014, 00:00 AM by Michael Croft
    SAN DIEGO, CA, US - Jun 19, 2014 - At the Drug Information Association’s (DIA) 50th Annual Meeting, Veeva Systems released the results of the Veeva 2014 Paperless TMF Survey: An Industry Benchmark, the largest TMF survey to date
    Full story
  • TEXT ANALYTICS COMPANY LINGUAMATICS BOOSTS ENTERPRISE SEARCH WITH SEMANTIC ENRICHMENT

    Jun 19, 2014, 00:00 AM by Michael Croft
    BOSTON, MA - Jun 19, 2014 - Today, Linguamatics launches I2E Semantic Enrichment to provide increased return on investment in enterprise search systems and radically improve speed to insight
    Full story
  • TELCOR’s QML® Achieves ONC HIT 2014 Edition Modular Certification from ICSA Labs

    Jun 19, 2014, 00:00 AM by Michael Croft
    LINCOLN, NE - Jun 19, 2014 - TELCOR's QML version 2.3 point of care software solution has achieved ONC HIT 2014 Edition Modular Inpatient and Modular Ambulatory EHR Certification, which designates that the software is capable of supporting eligible providers and hospitals with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA)
    Full story
  • HudsonAlpha and University of Alabama Birmingham Launch Center for Genomic Medicine

    Jun 18, 2014, 12:00 PM by Michael Croft
    Alabama.com | The HudsonAlpha Institute for Biotechnology and the University of Alabama at Birmingham School of Medicine are expanding and formalizing their relationship as the UAB-HudsonAlpha Center for Genomic Medicine
    Full story
  • MAVERIX ADDS SIGNIFICANT ENHANCEMENTS TO GENOMIC ANALYSIS PLATFORM FOR RNA-SEQ RESEARCH

    Jun 18, 2014, 00:00 AM by Michael Croft
    SAN MATEO, CA - Jun 18, 2014 - MAVERIX ADDS SIGNIFICANT ENHANCEMENTS TOGENOMIC ANALYSIS PLATFORMFOR RNA-SEQ RESEARCHEnhanced design allows comparison of side-by-side resultsfrom HTSeq/DESeq and CufflinksMaverix Biomics Inc
    Full story
  • Scripps, USC Considering Joining Efforts

    Jun 17, 2014, 10:00 AM by Michael Croft
    San Diego Union-Tribune | The Scripps Research Institute in La Jolla and the University of Southern California are reportedly considering a merger or acquisition, under which Scripps would be acquired by USC.
    Full story
  • Myriad Challenges Pathway Genomics' BRCATrue Test

    Jun 16, 2014, 09:00 AM by Michael Croft
    Bio-IT World Brief | Ten days after Pathway Genomics announced its new BRCATrue test and its plan to donate $10 million worth of tests in its one for one program, Myriad Genetics filed a patent infringement suit against the company. While calling the suit "unwarranted", Jim Plante, Pathway Genomics' founder and CEO, also acknowledged that the lawsuit was "not unexpected."
    Full story
  • The Coming Wave of Generic Biologics

    Jun 13, 2014, 11:20 AM by Michael Croft
    Forbes | Matthew Herper examines the market for generic biotech therapies, which have sometimes been seen as more resistant to generic competition than chemically manufactured drugs.
    Full story
  • May-June News and Product Briefs

    Jun 13, 2014, 08:20 AM by Michael Croft
    Bio-IT World | News and product releases from around the industry, including Myriad Genetics donating cancer variants to PROMPT study, and the launch of MolecularHealth's cancer genotyping service.
    Full story
  • Moderna Remaking Itself as mRNA Startup Incubator

    Jun 12, 2014, 13:40 PM by Michael Croft
    Xconomy | With over $400 million on hand, Cambridge-based Moderna Therapeutics is revisiting its role in bringing mRNA-based therapies to market.
    Full story
  • NextCODE Brings the deCODE Data Architecture to Tumor Analysis

    Jun 12, 2014, 12:30 PM by Michael Croft
    Bio-IT World | NextCODE Health, the spin-off from deCODE genetics that launched last October, has continued to release new software tools based on deCODE's former diagnostic services. Its latest is a whole genome-scale tumor analyzer.
    Full story
  • CEE Offers an Optimized Path for Biosimilar Research Execution, says KCR

    Jun 12, 2014, 00:00 AM by Michael Croft
    WARSAW, POLAND - Jun 12, 2014 - Warsaw – 12 June 2014 – Europe was the first region worldwide to introduce a clear regulatory pathway for biosimilar medicines
    Full story
  • TeraDiscoveries Announces Name Change to Cloud Pharmaceuticals, Inc.

    Jun 12, 2014, 00:00 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC, UNITED STATES - Jun 12, 2014 - TeraDiscoveries, Inc., a bio-therapeutics company focused on cloud-based drug design and development, announced today that effective immediately, it has changed its corporate name to Cloud Pharmaceuticals, Inc
    Full story
  • Claron Technology Ranks No. 305 on the 2014 PROFIT 500

    Jun 12, 2014, 00:00 AM by Michael Croft
    TORONTO, ON, CANADA - Jun 12, 2014 - Claron Technology, a leading medical imaging solution provider, was ranked today as No. 305 on the Canadian Business and PROFIT 26th annual PROFIT 500, the definitive ranking of Canada’s Fastest-Growing Companies
    Full story
  • First Reads from Nanopore Sequencers Becoming Public

    Jun 11, 2014, 08:30 AM by Michael Croft
    Bio-IT World News Brief | This morning, a trio of U.K. researchers released what may be the first publicly available read from an Oxford Nanopore MinION Sequencer.
    Full story
  • «
  • 391
  • 392
  • 393
  • 394
  • 395
  • 396
  • 397
  • 398
  • 399
  • 400 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy